{
    "medicine_id": "9efa140dff318b4963321a6b86e34b7e7fd2028b",
    "platform_id": "DB09543",
    "metadata": {
        "name": "1st Medxpatch With Lidocaine 4 10 g 100g Ointment",
        "composition": "10 g 100g Methyl salicylate",
        "clinical_particulars": {
            "therapeutic_indications": "Ointments or liniments containing methyl salicylate are applied topically as counter irritant for relief of acute pain associated with lumbago sciatica and rheumatic conditions Local analgesics for human and veterinary medicine",
            "contraindications": {
                "disease": "Oral LD50 values mg kg for mouse rat and rabbit are 1110 887 and 1300 respectively Oral LD50 values for child and adult human mg kg are 228 and 506 respectively Although systemic toxicity from topical administration is rare methyl salicylate can be absorbed in intract skin to cause stimulation of the central nervous system respiratory center disturbance of lipid and carbohydrate metabolism and disturbance of intracellular respiration Severe toxicity can result in acute lung injury lethargy coma seizures cerebral edema and death In case of salicylate poisoning the treatment consists of general supportive care gastrointestinal decontamination with activated charcoal in cases of salicylate ingestion and monitoring of serum salicylate concentrations Bicarbonate infusions or hemodialysis can be used to achieve enhanced salicylate elimination A19287",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Methyl salicylate relieve musculoskeletal pain in the muscles joints and tendons by causing irritation and reddening of the skin due to dilated capillaries and increased blood flow It is pharmacologically similar to aspirin and other NSAIDs but as a topical agent it primarily acts as a rubefacient and skin irritant Counter irritation is believed to cause a soothing sensation of warmth",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB06767",
                        "description": "The serum concentration of Methyl salicylate can be increased when it is combined with Ammonium chloride"
                    },
                    {
                        "drugbank-id": "DB01381",
                        "description": "Ginkgo biloba may increase the anticoagulant activities of Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The serum concentration of Methotrexate can be increased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB06813",
                        "description": "The serum concentration of Pralatrexate can be increased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "The therapeutic efficacy of Probenecid can be decreased when used in combination with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of bleeding can be increased when Treprostinil is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "The risk or severity of bleeding and gastrointestinal bleeding can be increased when Methyl salicylate is combined with Ketoprofen"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "The risk or severity of bleeding and gastrointestinal bleeding can be increased when Methyl salicylate is combined with Dexketoprofen"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "Methyl salicylate may increase the anticoagulant activities of Coumarin"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The serum concentration of Digoxin can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00511",
                        "description": "The serum concentration of Acetyldigitoxin can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB01078",
                        "description": "The serum concentration of Deslanoside can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB01092",
                        "description": "The serum concentration of Ouabain can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The serum concentration of Digitoxin can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB12843",
                        "description": "The serum concentration of Oleandrin can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB13240",
                        "description": "The serum concentration of Cymarin can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB13307",
                        "description": "The serum concentration of Proscillaridin can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "The serum concentration of Metildigoxin can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB13467",
                        "description": "The serum concentration of Lanatoside C can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB13537",
                        "description": "The serum concentration of Gitoformate can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The serum concentration of Acetyldigoxin can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB13756",
                        "description": "The serum concentration of Peruvoside can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00352",
                        "description": "The metabolism of Tioguanine can be decreased when combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00993",
                        "description": "The metabolism of Azathioprine can be decreased when combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB01033",
                        "description": "The metabolism of Mercaptopurine can be decreased when combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00001",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Lepirudin"
                    },
                    {
                        "drugbank-id": "DB00006",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Bivalirudin"
                    },
                    {
                        "drugbank-id": "DB00009",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Alteplase"
                    },
                    {
                        "drugbank-id": "DB00013",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Urokinase"
                    },
                    {
                        "drugbank-id": "DB00015",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Reteplase"
                    },
                    {
                        "drugbank-id": "DB00029",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Anistreplase"
                    },
                    {
                        "drugbank-id": "DB00031",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Tenecteplase"
                    },
                    {
                        "drugbank-id": "DB00054",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00055",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Drotrecogin alfa"
                    },
                    {
                        "drugbank-id": "DB00086",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Streptokinase"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Dicoumarol"
                    },
                    {
                        "drugbank-id": "DB00278",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Argatroban"
                    },
                    {
                        "drugbank-id": "DB00407",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Ardeparin"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Phenindione"
                    },
                    {
                        "drugbank-id": "DB00569",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Fondaparinux"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Warfarin"
                    },
                    {
                        "drugbank-id": "DB00686",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Pentosan polysulfate"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Phenprocoumon"
                    },
                    {
                        "drugbank-id": "DB00975",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Dipyridamole"
                    },
                    {
                        "drugbank-id": "DB01088",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Iloprost"
                    },
                    {
                        "drugbank-id": "DB01109",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Heparin"
                    },
                    {
                        "drugbank-id": "DB01225",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Enoxaparin"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Acenocoumarol"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with 4 hydroxycoumarin"
                    },
                    {
                        "drugbank-id": "DB04898",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Ximelagatran"
                    },
                    {
                        "drugbank-id": "DB04925",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Desmoteplase"
                    },
                    {
                        "drugbank-id": "DB04932",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Defibrotide"
                    },
                    {
                        "drugbank-id": "DB05099",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Ancrod"
                    },
                    {
                        "drugbank-id": "DB05229",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Beraprost"
                    },
                    {
                        "drugbank-id": "DB05254",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Fibrinolysin"
                    },
                    {
                        "drugbank-id": "DB06209",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Prasugrel"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Rivaroxaban"
                    },
                    {
                        "drugbank-id": "DB06271",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Sulodexide"
                    },
                    {
                        "drugbank-id": "DB06294",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Semuloparin"
                    },
                    {
                        "drugbank-id": "DB06406",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Idraparinux"
                    },
                    {
                        "drugbank-id": "DB06441",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Cangrelor"
                    },
                    {
                        "drugbank-id": "DB06543",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Astaxanthin"
                    },
                    {
                        "drugbank-id": "DB06605",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Apixaban"
                    },
                    {
                        "drugbank-id": "DB06635",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Otamixaban"
                    },
                    {
                        "drugbank-id": "DB06679",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Amediplase"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Dabigatran etexilate"
                    },
                    {
                        "drugbank-id": "DB06754",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Danaparoid"
                    },
                    {
                        "drugbank-id": "DB06779",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Dalteparin"
                    },
                    {
                        "drugbank-id": "DB06822",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Tinzaparin"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Ferulic acid"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with R warfarin"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Ethyl biscoumacetate"
                    },
                    {
                        "drugbank-id": "DB08813",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Nadroparin"
                    },
                    {
                        "drugbank-id": "DB08814",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Triflusal"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Ticagrelor"
                    },
                    {
                        "drugbank-id": "DB08994",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Ditazole"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Vorapaxar"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Edoxaban"
                    },
                    {
                        "drugbank-id": "DB09125",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Potassium citrate"
                    },
                    {
                        "drugbank-id": "DB09154",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Sodium citrate"
                    },
                    {
                        "drugbank-id": "DB09255",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Dextran"
                    },
                    {
                        "drugbank-id": "DB09258",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Bemiparin"
                    },
                    {
                        "drugbank-id": "DB09260",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Parnaparin"
                    },
                    {
                        "drugbank-id": "DB11095",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Desirudin"
                    },
                    {
                        "drugbank-id": "DB11154",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Zinc citrate"
                    },
                    {
                        "drugbank-id": "DB11166",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Antithrombin Alfa"
                    },
                    {
                        "drugbank-id": "DB11312",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Protein C"
                    },
                    {
                        "drugbank-id": "DB11598",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Antithrombin III human"
                    },
                    {
                        "drugbank-id": "DB11984",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Letaxaban"
                    },
                    {
                        "drugbank-id": "DB12289",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Darexaban"
                    },
                    {
                        "drugbank-id": "DB12364",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Betrixaban"
                    },
                    {
                        "drugbank-id": "DB12598",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB12726",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Monteplase"
                    },
                    {
                        "drugbank-id": "DB12831",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Gabexate"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Fluindione"
                    },
                    {
                        "drugbank-id": "DB13149",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13199",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Brinase"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Clorindione"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Diphenadione"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Tioclomarol"
                    },
                    {
                        "drugbank-id": "DB13616",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Melagatran"
                    },
                    {
                        "drugbank-id": "DB13646",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Saruplase"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with S Warfarin"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Tocopherylquinone"
                    },
                    {
                        "drugbank-id": "DB14598",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Edetate calcium disodium anhydrous"
                    },
                    {
                        "drugbank-id": "DB14726",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Dabigatran"
                    },
                    {
                        "drugbank-id": "DB13124",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Troxerutin"
                    },
                    {
                        "drugbank-id": "DB00974",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Edetic acid"
                    },
                    {
                        "drugbank-id": "DB09259",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Reviparin"
                    },
                    {
                        "drugbank-id": "DB00030",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Insulin human"
                    },
                    {
                        "drugbank-id": "DB00046",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Insulin lispro"
                    },
                    {
                        "drugbank-id": "DB00047",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Insulin glargine"
                    },
                    {
                        "drugbank-id": "DB00071",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Insulin pork"
                    },
                    {
                        "drugbank-id": "DB00197",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Troglitazone"
                    },
                    {
                        "drugbank-id": "DB00222",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Glimepiride"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Sulfisoxazole"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00284",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Acarbose"
                    },
                    {
                        "drugbank-id": "DB00331",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Metformin"
                    },
                    {
                        "drugbank-id": "DB00359",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Sulfadiazine"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Rosiglitazone"
                    },
                    {
                        "drugbank-id": "DB00414",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Acetohexamide"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Quinine"
                    },
                    {
                        "drugbank-id": "DB00491",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Miglitol"
                    },
                    {
                        "drugbank-id": "DB00672",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Chlorpropamide"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Nateglinide"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Pentamidine"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00839",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Tolazamide"
                    },
                    {
                        "drugbank-id": "DB00912",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Repaglinide"
                    },
                    {
                        "drugbank-id": "DB00914",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Phenformin"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Sulfamethoxazole"
                    },
                    {
                        "drugbank-id": "DB01016",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Glyburide"
                    },
                    {
                        "drugbank-id": "DB01067",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Glipizide"
                    },
                    {
                        "drugbank-id": "DB01120",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Gliclazide"
                    },
                    {
                        "drugbank-id": "DB01124",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Tolbutamide"
                    },
                    {
                        "drugbank-id": "DB01132",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Pioglitazone"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Bromocriptine"
                    },
                    {
                        "drugbank-id": "DB01251",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Gliquidone"
                    },
                    {
                        "drugbank-id": "DB01252",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Mitiglinide"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Sitagliptin"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Sunitinib"
                    },
                    {
                        "drugbank-id": "DB01276",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Exenatide"
                    },
                    {
                        "drugbank-id": "DB01277",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Mecasermin"
                    },
                    {
                        "drugbank-id": "DB01278",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Pramlintide"
                    },
                    {
                        "drugbank-id": "DB01289",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Glisoxepide"
                    },
                    {
                        "drugbank-id": "DB01306",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Insulin aspart"
                    },
                    {
                        "drugbank-id": "DB01307",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Insulin detemir"
                    },
                    {
                        "drugbank-id": "DB01309",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Insulin glulisine"
                    },
                    {
                        "drugbank-id": "DB01382",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Glymidine"
                    },
                    {
                        "drugbank-id": "DB01700",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of AICA ribonucleotide"
                    },
                    {
                        "drugbank-id": "DB04830",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Buformin"
                    },
                    {
                        "drugbank-id": "DB04876",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Vildagliptin"
                    },
                    {
                        "drugbank-id": "DB04878",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Voglibose"
                    },
                    {
                        "drugbank-id": "DB05115",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of NN344"
                    },
                    {
                        "drugbank-id": "DB05819",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of NBI 6024"
                    },
                    {
                        "drugbank-id": "DB06011",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of AMG 222"
                    },
                    {
                        "drugbank-id": "DB06127",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Bisegliptin"
                    },
                    {
                        "drugbank-id": "DB06203",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Alogliptin"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Dapagliflozin"
                    },
                    {
                        "drugbank-id": "DB06335",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Saxagliptin"
                    },
                    {
                        "drugbank-id": "DB06655",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Liraglutide"
                    },
                    {
                        "drugbank-id": "DB08382",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Gosogliptin"
                    },
                    {
                        "drugbank-id": "DB08882",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Linagliptin"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08962",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Glibornuride"
                    },
                    {
                        "drugbank-id": "DB09022",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Benfluorex"
                    },
                    {
                        "drugbank-id": "DB09038",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Empagliflozin"
                    },
                    {
                        "drugbank-id": "DB09043",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Albiglutide"
                    },
                    {
                        "drugbank-id": "DB09045",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Dulaglutide"
                    },
                    {
                        "drugbank-id": "DB09198",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Lobeglitazone"
                    },
                    {
                        "drugbank-id": "DB09199",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Netoglitazone"
                    },
                    {
                        "drugbank-id": "DB09200",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Rivoglitazone"
                    },
                    {
                        "drugbank-id": "DB09201",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Ciglitazone"
                    },
                    {
                        "drugbank-id": "DB09265",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Lixisenatide"
                    },
                    {
                        "drugbank-id": "DB09456",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Insulin beef"
                    },
                    {
                        "drugbank-id": "DB09564",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Insulin degludec"
                    },
                    {
                        "drugbank-id": "DB11567",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Insulin peglispro"
                    },
                    {
                        "drugbank-id": "DB11568",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Insulin tregopil"
                    },
                    {
                        "drugbank-id": "DB11698",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Ipragliflozin"
                    },
                    {
                        "drugbank-id": "DB11723",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Dutogliptin"
                    },
                    {
                        "drugbank-id": "DB11780",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Allicin"
                    },
                    {
                        "drugbank-id": "DB11824",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Tofogliflozin"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Ertugliflozin"
                    },
                    {
                        "drugbank-id": "DB11898",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of 2 4 thiazolidinedione"
                    },
                    {
                        "drugbank-id": "DB11950",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Teneligliptin"
                    },
                    {
                        "drugbank-id": "DB11992",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Omarigliptin"
                    },
                    {
                        "drugbank-id": "DB12268",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Carmegliptin"
                    },
                    {
                        "drugbank-id": "DB12412",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Gemigliptin"
                    },
                    {
                        "drugbank-id": "DB12417",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Anagliptin"
                    },
                    {
                        "drugbank-id": "DB12625",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Evogliptin"
                    },
                    {
                        "drugbank-id": "DB12713",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Sotagliflozin"
                    },
                    {
                        "drugbank-id": "DB12781",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Balaglitazone"
                    },
                    {
                        "drugbank-id": "DB12935",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Remogliflozin etabonate"
                    },
                    {
                        "drugbank-id": "DB13406",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Carbutamide"
                    },
                    {
                        "drugbank-id": "DB13446",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Guar gum"
                    },
                    {
                        "drugbank-id": "DB13675",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Metahexamide"
                    },
                    {
                        "drugbank-id": "DB13928",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Semaglutide"
                    },
                    {
                        "drugbank-id": "DB14027",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Taspoglutide"
                    },
                    {
                        "drugbank-id": "DB14035",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Englitazone"
                    },
                    {
                        "drugbank-id": "DB15171",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Tirzepatide"
                    },
                    {
                        "drugbank-id": "DB15217",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Gastric inhibitory polypeptide"
                    },
                    {
                        "drugbank-id": "DB00178",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Ramipril"
                    },
                    {
                        "drugbank-id": "DB00492",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Fosinopril"
                    },
                    {
                        "drugbank-id": "DB00519",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Trandolapril"
                    },
                    {
                        "drugbank-id": "DB00542",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Benazepril"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Enalapril"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Moexipril"
                    },
                    {
                        "drugbank-id": "DB00722",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Lisinopril"
                    },
                    {
                        "drugbank-id": "DB00790",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Perindopril"
                    },
                    {
                        "drugbank-id": "DB00881",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Quinapril"
                    },
                    {
                        "drugbank-id": "DB00886",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Omapatrilat"
                    },
                    {
                        "drugbank-id": "DB01180",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Rescinnamine"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Captopril"
                    },
                    {
                        "drugbank-id": "DB01340",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Cilazapril"
                    },
                    {
                        "drugbank-id": "DB01348",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Spirapril"
                    },
                    {
                        "drugbank-id": "DB08836",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Temocapril"
                    },
                    {
                        "drugbank-id": "DB09477",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Enalaprilat"
                    },
                    {
                        "drugbank-id": "DB11783",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Imidapril"
                    },
                    {
                        "drugbank-id": "DB13166",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Zofenopril"
                    },
                    {
                        "drugbank-id": "DB13312",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Delapril"
                    },
                    {
                        "drugbank-id": "DB14125",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Benazeprilat"
                    },
                    {
                        "drugbank-id": "DB14207",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Fosinoprilat"
                    },
                    {
                        "drugbank-id": "DB14208",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Ramiprilat"
                    },
                    {
                        "drugbank-id": "DB14209",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Trandolaprilat"
                    },
                    {
                        "drugbank-id": "DB14210",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Moexiprilat"
                    },
                    {
                        "drugbank-id": "DB14213",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Perindoprilat"
                    },
                    {
                        "drugbank-id": "DB14217",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Quinaprilat"
                    },
                    {
                        "drugbank-id": "DB14231",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Quinoline Yellow WS"
                    },
                    {
                        "drugbank-id": "DB15565",
                        "description": "The risk or severity of renal failure can be increased when Methyl salicylate is combined with Cilazaprilat"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "The risk or severity of adverse effects can be increased when Methyl salicylate is combined with Torasemide"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "The risk or severity of adverse effects can be increased when Methyl salicylate is combined with Bumetanide"
                    },
                    {
                        "drugbank-id": "DB00903",
                        "description": "The risk or severity of adverse effects can be increased when Methyl salicylate is combined with Etacrynic acid"
                    },
                    {
                        "drugbank-id": "DB02925",
                        "description": "The risk or severity of adverse effects can be increased when Methyl salicylate is combined with Piretanide"
                    },
                    {
                        "drugbank-id": "DB08961",
                        "description": "The risk or severity of adverse effects can be increased when Methyl salicylate is combined with Azosemide"
                    },
                    {
                        "drugbank-id": "DB00311",
                        "description": "The risk or severity of adverse effects can be increased when Methyl salicylate is combined with Ethoxzolamide"
                    },
                    {
                        "drugbank-id": "DB00703",
                        "description": "The risk or severity of adverse effects can be increased when Methyl salicylate is combined with Methazolamide"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "The risk or severity of adverse effects can be increased when Methyl salicylate is combined with Acetazolamide"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The risk or severity of adverse effects can be increased when Methyl salicylate is combined with Zonisamide"
                    },
                    {
                        "drugbank-id": "DB01144",
                        "description": "The risk or severity of adverse effects can be increased when Methyl salicylate is combined with Diclofenamide"
                    },
                    {
                        "drugbank-id": "DB00233",
                        "description": "The risk or severity of bleeding nephrotoxicity and gastrointestinal bleeding can be increased when Aminosalicylic acid is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "The risk or severity of bleeding nephrotoxicity and gastrointestinal bleeding can be increased when Salicylic acid is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "The risk or severity of bleeding nephrotoxicity and gastrointestinal bleeding can be increased when Olsalazine is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB01294",
                        "description": "The risk or severity of bleeding nephrotoxicity and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB06251",
                        "description": "The risk or severity of bleeding nephrotoxicity and gastrointestinal bleeding can be increased when Dersalazine is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB06807",
                        "description": "The risk or severity of bleeding nephrotoxicity and gastrointestinal bleeding can be increased when Phenyl aminosalicylate is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB13509",
                        "description": "The risk or severity of bleeding nephrotoxicity and gastrointestinal bleeding can be increased when Methyl salicylate is combined with Aloxiprin"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "The risk or severity of bleeding nephrotoxicity and gastrointestinal bleeding can be increased when Methyl salicylate is combined with Guacetisal"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "The risk or severity of bleeding nephrotoxicity and gastrointestinal bleeding can be increased when Methyl salicylate is combined with Carbaspirin calcium"
                    },
                    {
                        "drugbank-id": "DB14006",
                        "description": "The risk or severity of bleeding nephrotoxicity and gastrointestinal bleeding can be increased when Methyl salicylate is combined with Choline salicylate"
                    },
                    {
                        "drugbank-id": "DB14026",
                        "description": "The risk or severity of bleeding nephrotoxicity and gastrointestinal bleeding can be increased when Methyl salicylate is combined with Thiosalicylic acid"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The serum concentration of Valproic acid can be increased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Icosapent"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Mesalazine"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Indomethacin"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Nabumetone"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Ketorolac"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Tenoxicam"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Tolmetin"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Piroxicam"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Fenoprofen"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Diclofenac"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Sulindac"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Flurbiprofen"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Etodolac"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Mefenamic acid"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Naproxen"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Sulfasalazine"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Phenylbutazone"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Meloxicam"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Carprofen"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Diflunisal"
                    },
                    {
                        "drugbank-id": "DB00870",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Suprofen"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Meclofenamic acid"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Acetylsalicylic acid"
                    },
                    {
                        "drugbank-id": "DB00963",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Bromfenac"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Oxaprozin"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Balsalazide"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Magnesium salicylate"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Salsalate"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Choline magnesium trisalicylate"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Antrafenine"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Antipyrine"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Tiaprofenic acid"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Lornoxicam"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Aceclofenac"
                    },
                    {
                        "drugbank-id": "DB06802",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Nepafenac"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Dexibuprofen"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Droxicam"
                    },
                    {
                        "drugbank-id": "DB11079",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Trolamine salicylate"
                    },
                    {
                        "drugbank-id": "DB13346",
                        "description": "The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Bufexamac"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The risk or severity of bleeding can be increased when Diltiazem is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The risk or severity of bleeding can be increased when Verapamil is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00180",
                        "description": "The serum concentration of Flunisolide can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The serum concentration of Betamethasone can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The serum concentration of Triamcinolone can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "The serum concentration of Prednisone can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00687",
                        "description": "The serum concentration of Fludrocortisone can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "The serum concentration of Hydrocortisone can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00860",
                        "description": "The serum concentration of Prednisolone can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00959",
                        "description": "The serum concentration of Methylprednisolone can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB01108",
                        "description": "The serum concentration of Trilostane can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "The serum concentration of Budesonide can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The serum concentration of Dexamethasone can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB01285",
                        "description": "The serum concentration of Corticotropin can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The serum concentration of Cortisone acetate can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "The serum concentration of Paramethasone can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB04630",
                        "description": "The serum concentration of Aldosterone can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB09378",
                        "description": "The serum concentration of Fluprednisolone can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "The serum concentration of Meprednisone can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB11529",
                        "description": "The serum concentration of Melengestrol can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "The serum concentration of Deflazacort can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "The serum concentration of Cortivazol can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "The serum concentration of Prednylidene can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "The serum concentration of Cloprednol can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB14681",
                        "description": "The serum concentration of Cortisone can be decreased when it is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00063",
                        "description": "The risk or severity of bleeding can be increased when Eptifibatide is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The risk or severity of bleeding can be increased when Ticlopidine is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00758",
                        "description": "The risk or severity of bleeding can be increased when Clopidogrel is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00775",
                        "description": "The risk or severity of bleeding can be increased when Tirofiban is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "The risk or severity of bleeding can be increased when Pentoxifylline is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB01138",
                        "description": "The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of bleeding can be increased when Cilostazol is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB01207",
                        "description": "The risk or severity of bleeding can be increased when Ridogrel is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of bleeding can be increased when Sevoflurane is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB02709",
                        "description": "The risk or severity of bleeding can be increased when Resveratrol is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "The risk or severity of bleeding can be increased when Nimesulide is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "The risk or severity of bleeding can be increased when Tesmilifene is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB05266",
                        "description": "The risk or severity of bleeding can be increased when Ibudilast is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB05767",
                        "description": "The risk or severity of bleeding can be increased when Andrographolide is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB06081",
                        "description": "The risk or severity of bleeding can be increased when Caplacizumab is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "The risk or severity of bleeding can be increased when Tranilast is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB08887",
                        "description": "The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB09283",
                        "description": "The risk or severity of bleeding can be increased when Trapidil is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "The risk or severity of bleeding can be increased when Naftopidil is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "The risk or severity of bleeding can be increased when Sarpogrelate is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB12321",
                        "description": "The risk or severity of bleeding can be increased when Ifetroban is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "The risk or severity of bleeding can be increased when Nitroaspirin is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "The risk or severity of bleeding can be increased when Ketanserin is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "The risk or severity of bleeding can be increased when Indobufen is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB12749",
                        "description": "The risk or severity of bleeding can be increased when Butylphthalide is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB12771",
                        "description": "The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB13036",
                        "description": "The risk or severity of bleeding can be increased when Ramatroban is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB13327",
                        "description": "The risk or severity of bleeding can be increased when Picotamide is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB13367",
                        "description": "The risk or severity of bleeding can be increased when Cloricromen is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "The risk or severity of bleeding can be increased when Linsidomine is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB13510",
                        "description": "The risk or severity of bleeding can be increased when Buflomedil is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB13929",
                        "description": "The risk or severity of bleeding can be increased when Relcovaptan is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB10076",
                        "description": "The risk or severity of adverse effects can be increased when Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB10342",
                        "description": "The risk or severity of adverse effects can be increased when Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB10600",
                        "description": "The risk or severity of adverse effects can be increased when Influenza A virus A California 7 2009 X 181 H1N1 antigen propiolactone inactivated is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB10794",
                        "description": "The risk or severity of adverse effects can be increased when Influenza B virus B Brisbane 60 2008 antigen formaldehyde inactivated is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB10990",
                        "description": "The risk or severity of adverse effects can be increased when Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB11038",
                        "description": "The risk or severity of adverse effects can be increased when Influenza A virus A Brisbane 59 2007 H1N1 hemagglutinin antigen propiolactone inactivated is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB11040",
                        "description": "The risk or severity of adverse effects can be increased when Influenza B virus B Brisbane 60 2008 hemagglutinin antigen propiolactone inactivated is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB11041",
                        "description": "The risk or severity of adverse effects can be increased when Influenza A virus A California 7 2009 X 181 H1N1 hemagglutinin antigen propiolactone inactivated is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB11044",
                        "description": "The risk or severity of adverse effects can be increased when Influenza B virus B Brisbane 60 2008 antigen propiolactone inactivated is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB14384",
                        "description": "The risk or severity of adverse effects can be increased when Influenza A virus A Victoria 210 2009 X 187 H3N2 hemagglutinin antigen formaldehyde inactivated is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB14385",
                        "description": "The risk or severity of adverse effects can be increased when Influenza B virus B Brisbane 60 2008 hemagglutinin antigen formaldehyde inactivated is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB14394",
                        "description": "The risk or severity of adverse effects can be increased when Influenza A virus A California 7 2009 H1N1 live attenuated antigen is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB14445",
                        "description": "The risk or severity of adverse effects can be increased when Influenza A virus A Victoria 210 2009 X 187 H3N2 antigen formaldehyde inactivated is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB14449",
                        "description": "The risk or severity of adverse effects can be increased when Influenza A virus A Perth 16 2009 H3N2 live attenuated antigen is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB14619",
                        "description": "The risk or severity of adverse effects can be increased when Influenza A virus A Uruguay 716 2007 H3N2 antigen propiolactone inactivated is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB14620",
                        "description": "The risk or severity of adverse effects can be increased when Influenza A virus A Brisbane 59 2007 H1N1 antigen propiolactone inactivated is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB09413",
                        "description": "The serum concentration of Methyl salicylate can be increased when it is combined with Monopotassium phosphate"
                    },
                    {
                        "drugbank-id": "DB10318",
                        "description": "The risk or severity of adverse effects can be increased when Methyl salicylate is combined with Varicella Zoster Vaccine Live attenuated"
                    },
                    {
                        "drugbank-id": "DB00024",
                        "description": "The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00279",
                        "description": "The therapeutic efficacy of Liothyronine can be increased when used in combination with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00451",
                        "description": "The therapeutic efficacy of Levothyroxine can be increased when used in combination with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB01583",
                        "description": "The therapeutic efficacy of Liotrix can be increased when used in combination with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB03604",
                        "description": "The therapeutic efficacy of Tiratricol can be increased when used in combination with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB09100",
                        "description": "The therapeutic efficacy of Thyroid porcine can be increased when used in combination with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "The risk or severity of adverse effects can be increased when Acetaminophen is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The risk or severity of adverse effects can be increased when Propacetamol is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "The risk or severity of adverse effects can be increased when Methyl salicylate is combined with Furosemide"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The protein binding of Phenytoin can be decreased when combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The protein binding of Fosphenytoin can be decreased when combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB00869",
                        "description": "The risk or severity of metabolic acidosis can be increased when Dorzolamide is combined with Methyl salicylate"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}